Efficacy and safety of consolidation durvalumab after chemoradiation therapy for stage III non-small-cell lung cancer: a systematic review, meta-analysis, and meta-regression of real-world studies

Background: The current review aimed to pool real-world evidence on the efficacy and toxicity of consolidation durvalumab for stage III unresectable non-small cell lung cancer (NSCLC) after curative chemoradiotherapy. Methods: PubMed, CENTRAL, ScienceDirect, Embase, and Google Scholar were searched...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yatong, Tian, Yumei, Zheng, Li, Sun, Xuelin, Zhao, Zinan, Zheng, Yujing, Tian, Jinhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285075/
https://www.ncbi.nlm.nih.gov/pubmed/37361225
http://dx.doi.org/10.3389/fphar.2023.1103927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285075/
https://www.ncbi.nlm.nih.gov/pubmed/37361225
http://dx.doi.org/10.3389/fphar.2023.1103927

Ejemplares similares